Pictet Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $327M | Buy |
735,822
+74,635
| +11% | +$33.2M | 0.33% | 80 |
|
|
2025
Q1 | $322M | Buy |
661,187
+141,519
| +27% | +$68.9M | 0.36% | 76 |
|
|
2024
Q4 | $209M | Buy |
519,668
+1,665
| +0.3% | +$670K | 0.23% | 111 |
|
|
2024
Q3 | $240M | Sell |
518,003
-45,353
| -8% | -$21.1M | 0.26% | 99 |
|
|
2024
Q2 | $264M | Sell |
563,356
-434,938
| -44% | -$204M | 0.3% | 82 |
|
|
2024
Q1 | $417M | Sell |
998,294
-82,752
| -8% | -$34.6M | 0.45% | 51 |
|
|
2023
Q4 | $440M | Buy |
1,081,046
+22,231
| +2% | +$9.05M | 0.49% | 47 |
|
|
2023
Q3 | $368M | Buy |
+1,058,815
| New | +$368M | 0.45% | 54 |
|